CompletedNot Applicable

Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery

China80 participantsStarted 2015-05

Plain-language summary

The purpose of this study is to determine whether autologous platelet rich plasma (APRP)is effective in reducing allogeneic blood transfusions during aortic surgery using deep hypothermic circulatory arrest.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients undergoing elective or emergency aortic surgery using deep hypothermic circulatory arrest、 * preoperative platelet counts\>150000000000/L、 * preoperative hematocrit\>33%、 * without recent anticoagulants less than 5 days Exclusion Criteria: * preoperative coagulation disorder * severe renal and liver dysfunction * preoperative hemodynamic instability

What they're measuring

total perioperative allogenic transfusions of platelet and fresh frozen plasma

Timeframe: on the 7th day postoperatively

Trial details

NCT IDNCT02513862

SponsorHongwen Ji

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-06

View on ClinicalTrials.gov More C.Surgical Procedure; Cardiac trials